Investor Overview Press Releases August 27, 2021 Aclaris Therapeutics Announces Proposed Settlement and Settlement Hearing of Stockholder Derivative Action August 26, 2021 Aclaris Therapeutics to Participate in Upcoming Investor Conferences August 5, 2021 Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update View all » Events Sep 27, 20219:20 AM EDT Aclaris Therapeutics, Inc. at Cantor Virtual Global Healthcare Conference Sep 13, 20217:00 AM EDT Aclaris Therapeutics, Inc. at H.C. Wainwright 23rd Annual Global Investment Conference Jul 15, 202111:00 AM EDT Aclaris Therapeutics, Inc. at William Blair Biotech Focus Conference 2021 View all » Feature Presentation ATI-1777-AD-201 Preliminary Topline Data Presentation Derivative Stockholder Action Aclaris Therapeutics Company Overview - September 2021 H.C. Wainwright Global Investment Conference Presentation Notice of Pendency and Proposed Settlement of Stockholder Derivative Action
August 27, 2021 Aclaris Therapeutics Announces Proposed Settlement and Settlement Hearing of Stockholder Derivative Action
August 5, 2021 Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
Sep 13, 20217:00 AM EDT Aclaris Therapeutics, Inc. at H.C. Wainwright 23rd Annual Global Investment Conference
